Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 25, 2022
[ Wed, May 25th 2022
] - WOPRAI
[ Wed, May 25th 2022
] - WOPRAI
Tue, May 24, 2022
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
[ Tue, May 24th 2022
] - WOPRAI
Liisa Bayko Maintained (VRTX) at Buy and Held Target at $278 on, May 24th, 2022
Liisa Bayko of Evercore ISI Group, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $278 on, May 24th, 2022.
Liisa has made no other calls on VRTX in the last 4 months.
There are 11 other peers that have a rating on VRTX. Out of the 11 peers that are also analyzing VRTX, 6 agree with Liisa's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Risinger of "SVB Leerink" Initiated at Hold and Held Target at $265 on, Monday, May 23rd, 2022
- Do Kim of "Piper Sandler" Maintained at Hold with Decreased Target to $242 on, Friday, May 6th, 2022
- Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $267 on, Friday, May 6th, 2022
- Brian Skorney of "Baird" Downgraded from Buy to Hold on, Friday, May 6th, 2022
- Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $240 on, Thursday, May 5th, 2022
- Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $250 on, Tuesday, May 3rd, 2022
These are the ratings of the 5 analyists that currently disagree with Liisa
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $305 on, Friday, May 6th, 2022
- Gena Wang of "Barclays" Maintained at Buy and Held Target at $291 on, Thursday, May 5th, 2022
- Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $322 on, Wednesday, April 27th, 2022
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $350 on, Monday, April 4th, 2022
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $275 on, Thursday, January 27th, 2022
